Paul Chan

7.3k total citations · 1 hit paper
207 papers, 5.7k citations indexed

About

Paul Chan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Paul Chan has authored 207 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 55 papers in Cardiology and Cardiovascular Medicine and 47 papers in Surgery. Recurrent topics in Paul Chan's work include Lipoproteins and Cardiovascular Health (23 papers), Nitric Oxide and Endothelin Effects (14 papers) and Cardiac electrophysiology and arrhythmias (14 papers). Paul Chan is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), Nitric Oxide and Endothelin Effects (14 papers) and Cardiac electrophysiology and arrhythmias (14 papers). Paul Chan collaborates with scholars based in Taiwan, China and Hong Kong. Paul Chan's co-authors include Brian Tomlinson, Ju‐Chi Liu, Juei‐Tang Cheng, Yi‐Jen Chen, Tzu‐Hurng Cheng, Yuzhen Zhang, Zhong-Min Liu, Jen-Chen Tsai, Cheng‐I Lin and Yao‐Chang Chen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Paul Chan

205 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association

2017 341 citations Paul Chan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Chan Taiwan	39	1.6k	1.4k	898	748	692	207	5.7k
Soo‐Wan Chae South Korea	40	3.2k 2.1×	795 0.6×	535 0.6×	386 0.5×	432 0.6×	226	6.5k
Domenico Bonaduce Italy	36	1.5k 1.0×	2.3k 1.6×	417 0.5×	954 1.3×	875 1.3×	153	7.3k
Kailash Prasad Canada	42	1.4k 0.9×	1.1k 0.8×	1.3k 1.4×	1.7k 2.3×	815 1.2×	229	7.2k
David Della‐Morte Italy	39	2.0k 1.3×	1.3k 0.9×	511 0.6×	534 0.7×	669 1.0×	203	8.1k
James J. DiNicolantonio United States	49	1.1k 0.7×	1.5k 1.1×	1.3k 1.5×	988 1.3×	790 1.1×	194	6.9k
Ali H. Eid Qatar	49	2.8k 1.8×	745 0.5×	314 0.3×	643 0.9×	630 0.9×	250	8.2k
Giovambattista Desideri Italy	46	1.3k 0.8×	1.8k 1.3×	974 1.1×	1.9k 2.5×	1.2k 1.8×	216	7.7k
Pasquale Abete Italy	43	1.8k 1.2×	2.4k 1.7×	484 0.5×	368 0.5×	1.0k 1.5×	209	9.2k
Lindsay Brown Australia	52	2.6k 1.7×	1.4k 1.0×	1.4k 1.6×	1.8k 2.4×	824 1.2×	227	9.2k
H. Hendriks Netherlands	55	2.7k 1.8×	564 0.4×	1.2k 1.4×	1.7k 2.2×	689 1.0×	196	9.7k

Countries citing papers authored by Paul Chan

Since Specialization

Citations

This map shows the geographic impact of Paul Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Chan more than expected).

Fields of papers citing papers by Paul Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Chan. The network helps show where Paul Chan may publish in the future.

Co-authorship network of co-authors of Paul Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Chan. A scholar is included among the top collaborators of Paul Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Chan. Paul Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hui, C, Fred Lee, K. W. Fan, et al.. (2025). Ultrasound-Assisted Extraction: Unlocking the Antibacterial Potential of Coptis chinensis Franch. Against ESBL-Producing Enterobacterales. Molecules. 30(22). 4331–4331.

Pi, Jingjiang, Jie Liu, Huan J. Chang, et al.. (2024). Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 glycolysis signal to restrict angiogenesis. Redox Biology. 75. 103281–103281. 4 indexed citations

Chen, Xiaoli, Yanfang Wang, Jingjiang Pi, et al.. (2023). The Association of Lipoprotein(a) and Neutrophil-to-Lymphocyte Ratio Combination with Atherosclerotic Cardiovascular Disease in Chinese Patients. International Journal of General Medicine. Volume 16. 2805–2817. 6 indexed citations

Chen, Xiaoli, Jianfei Xu, Hongda Li, et al.. (2022). Endothelial Foxp1 Regulates Neointimal Hyperplasia Via Matrix Metalloproteinase‐9/Cyclin Dependent Kinase Inhibitor 1B Signal Pathway. Journal of the American Heart Association. 11(15). e026378–e026378. 8 indexed citations

Tomlinson, Brian, Yanhong Li, & Paul Chan. (2022). Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. 23(17). 1869–1877. 6 indexed citations

Tomlinson, Brian, Elaine Chow, Paul Chan, & Christopher Wai Kei Lam. (2021). An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease. Expert Opinion on Drug Metabolism & Toxicology. 17(12). 1353–1361. 7 indexed citations

Tomlinson, Brian, Nivritti G. Patil, Manson Fok, Paul Chan, & Christopher Wai Kei Lam. (2021). The role of sulfonylureas in the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy. 23(3). 387–403. 29 indexed citations

Wong, Kar‐Lok, et al.. (2020). Tannic acid, a vasodilator present in wines and beverages, stimulates Ca2+ influx via TRP channels in bEND.3 endothelial cells. Biochemical and Biophysical Research Communications. 526(1). 117–121. 9 indexed citations

Tomlinson, Brian, Paul Chan, Yuzhen Zhang, & Christopher Wai Kei Lam. (2020). Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy. Expert Opinion on Pharmacotherapy. 21(17). 2137–2151. 6 indexed citations

10.

Hsu, Feng‐Lin, Shih‐Chang Tsai, Ju‐Chi Liu, et al.. (2011). Tanshinone IIA attenuates cyclic strain‐induced endothelin‐1 expression in human umbilical vein endothelial cells. Clinical and Experimental Pharmacology and Physiology. 39(1). 63–68. 16 indexed citations

11.

Chan, Paul, et al.. (2008). Recurrent Deep Vein Thrombosis Caused by Inherited Coagulopathy in a Japanese Male. Zhōnghuá mínguó xīnzàngxué huì zázhì. 24(3). 157–160. 1 indexed citations

12.

Chan, Paul, et al.. (2007). The effects of simple eight-week regular exercise on cardiovascular disease risk factors in middle-aged women at risk in Taiwan. Zhōnghuá mínguó xīnzàngxué huì zázhì. 23(3). 169–176. 9 indexed citations

13.

Chan, Paul, et al.. (2004). Adult Giant Coronary Artery Aneurysm - A Case Report and Literature Review. Zhōnghuá mínguó xīnzàngxué huì zázhì. 20(3). 187–190. 3 indexed citations

14.

Chan, Paul, et al.. (2004). 17β-Estradiol Downregulates Angiotensin-II-Induced Endothelin-1 Gene Expression in Rat Aortic Smooth Muscle Cells. Journal of Biomedical Science. 11(1). 27–36. 26 indexed citations

15.

Tsai, Jen-Chen, Paul Chan, Brian Tomlinson, et al.. (2003). The Beneficial Effects of Tai Chi Chuan on Blood Pressure and Lipid Profile and Anxiety Status in a Randomized Controlled Trial. The Journal of Alternative and Complementary Medicine. 9(5). 747–754. 211 indexed citations

16.

Thomas, G. Neil, et al.. (2003). Statins in lipid-lowering therapy. Zhōnghuá mínguó xīnzàngxué huì zázhì. 19(1). 1–11. 1 indexed citations

17.

Hsieh, Ming H., et al.. (2001). THE ANTIHYPERTENSIVE EFFECTS OF STEVIOSIDE DERIVATIVE ISOSTEVIOL IN SPONTANEOUSLY HYPERTENSIVE RATS. Zhōnghuá mínguó xīnzàngxué huì zázhì. 17(3). 133–140. 30 indexed citations

18.

Chan, Paul, et al.. (2001). Effect of tetramethylpyrazine on blood pressure in hypertensive rats and calcium mobilization in vascular smooth muscle cells. Zhōnghuá mínguó xīnzàngxué huì zázhì. 17(1). 3–8. 1 indexed citations

19.

Chow, Jyh-Ming, et al.. (2000). Down-regulation of superoxide dismutase gene expression in cultured rat aortic smooth muscle cells (A7r5) after long-term incubation with vitamin C. Zhōnghuá mínguó xīnzàngxué huì zázhì. 16(4). 209–216. 2 indexed citations

20.

Chan, Paul, et al.. (1998). Effect of trilinolein on superoxide dismutase activity in isolated rat cardiomyocytes subjected to hypoxia and normoxic perfusion. Zhōnghuá mínguó xīnzàngxué huì zázhì. 14(2). 52–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact